Sinonasal malignancy: ESMO–EURACAN CPG for diagnosis, treatment and follow-up

Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up - European Society For Medical Oncology (ESMO) / European Reference Network for rare adult solid cancers (EURACAN)

• The CPG provides key recommendations and algorithms for managing SMs, excluding mucosal melanoma and soft-tissue sarcomas.

• The guideline covers diagnosis, staging, risk assessment, treatment and disease monitoring.

• Technological advancements in treatment with RT are discussed with a special focus on particle therapy.

• Surgical indications for open and transnasal endoscopic surgery are provided.

• Neoadjuvant chemotherapy in high-grade, locally advanced SMs helps to select subjects for conservative treatments.


Read full Guideline